Contrary to the situation in adulthood, gammabutyric acid (GABA) A receptor activation during early brain development depolarizes neurons sufficiently to open L-type voltage-gated Ca 2ϩ channels. Because GABA is excitatory during the sensitive period of steroid-mediated brain sexual differentiation, we investigated whether estradiol modulates excitatory GABA during this period, by examining two parameters: 1) magnitude of GABA-induced calcium transients; and 2) developmental duration of excitatory GABA. Dissociated hypothalamic neurons from embryonic-day-15 rat embryos were loaded with the Ca 2ϩ indicator, fura-2, and transient rises in [Ca 2ϩ ] i (Ca 2ϩ transient) were measured after application of 10 M muscimol, a GABA A receptor agonist. Cells were treated with 10 Ϫ10
or vehicle from 0 -3 days in vitro (DIV) and imaged on 4 DIV, whereas others were treated from 3-6 DIV and imaged on 7 DIV. The mean amplitude of Ca 2ϩ transients after muscimol administration were 68% and 61% higher in estradiol-treated neurons on 4 DIV and 7 DIV, respectively, relative to controls. Consistent with GABA becoming inhibitory in mature neurons, 50% fewer control neurons responded on DIV 7, relative to DIV 4. However, estradiol treatment maintained excitatory GABA on DIV 7 (72% in estradiol-treated vs. 35% in control). This is the first report of hormonal modulation of excitatory GABA, and it suggests that estradiol may mediate sexual differentiation by enhancing GABA-induced increases in intracellular Ca S TEROIDS ARE IMPORTANT regulators of gene expression in the brain during development and in the adult. In the rat, there is a developmental window beginning the last week of gestation and terminating a few days after birth, during which high levels of estradiol (aromatized from testicularly derived testosterone) masculinize the male brain (1) . Steroid-mediated effects during this period include alterations in dendritic spines, neuronal branching, myelination, and cell death and are the basis of adult sex differences in brain structure and function (2) . Estradiol also displays trophic properties in dissociated cell culture systems, enhancing the growth and arborization of axons and dendrites in organotypic cultures from various brain regions (3) . Despite the considerable in vivo and in vitro evidence for estradiol's trophic actions, the underlying cellular mechanisms remain poorly understood.
Several lines of evidence suggest that gammabutyric acid (GABA) can have excitatory, stimulatory effects early during development and then gradually switch to mediate inhibitory processes in the adult brain. For example, activation of the GABAergic system during early development stimulates PRL release in female rats, whereas this same activation inhibits PRL release in rats near puberty (4, 5) . GABA is excitatory in primary neuronal cultures from the developing hypothalamus (6) , hippocampus (7) , neocortex (8) , thalamus (9), cerebellum (10) , and spinal cord (11) and in adult brain after injury (12). Activity of specific chloride cotransporters (13) results in the Cl Ϫ reversal potential being more positive than the resting membrane potential. Under these conditions, activation of GABA A receptors enables Cl Ϫ fluxes that cause membrane depolarization, which, in turn, opens voltage-gated Ca 2ϩ channels (6, 9) . By causing depolarization and subsequently elevating intracellular calcium, excitatory GABA influences neuronal survival (9, 10), neurite outgrowth (14) , neuroblast motility (15), expression of neurogenesis-related proteins (16, 17) , and synapse formation (18) . Many of these same parameters are also influenced by estradiol.
It has been known, for some time, that estrogen-receptive neurons in the preoptic/anterior hypothalamic area of the rat brain are also GABAergic (19) . Because of this anatomical colocalization and the convergence in their effects, GABA is implicated as a mediator of estradiol's actions during the process of sexual differentiation (20) . GABA concentrations and messenger RNA (mRNA) levels for the rate-limiting enzyme in GABA synthesis, glutamic acid decarboxylase (GAD), are almost twice as high in the newborn male me-diobasal hypothalamus and CA1 of hippocampus, relative to female (21, 22) . These sex differences are developmentally and hormonally regulated (21, 22) . More importantly, the presence of functional GABA during the critical period is essential for the process of sexual differentiation. Using antisense oligonucleotides against GAD mRNA to reduce GABA levels, around the day of birth, results in deficient adult male sexual behavior (23) and disrupted estradiolmediated glial differentiation (24) .
In summary, we have demonstrated the ability of estradiol to enhance GABA synthesis early in development and have established the functional significance of GABA in the process of sexual differentiation. In the present study, we used an in vitro model system to examine the mechanism of GABA action at the cellular level and its modulation by estradiol. To achieve this end, dispersed neonatal hypothalamic neurons were loaded with the calcium indicator, fura-2. [Ca 2ϩ ] i (free intercellular level of calcium) was then measured during application of the GABA A receptor agonist, muscimol. The results demonstrate that estradiol pretreatment significantly enhances the frequency and magnitude of Ca 2ϩ transients evoked by muscimol, implicating a potential role for excitatory GABA in estradiol-mediated sexual differentiation.
Materials and Methods

Cell culture
Under sterile conditions, hypothalami were dissected from embryonic-day (ED)-15 embryos (10 -13) and placed into phenol red-free, sterile culture medium (SCM) [DMEM-F12 (Life Technologies, Inc., Grand Island, NY) with 10% dextran-treated charcoal-stripped FBS (Life Technologies, Inc.) and 0.5 ml antibiotic/antimicotic (10,000 U penicillin G sodium, 10,000 g streptomycin sulfate, 25 g Amphotericin B; Life Technologies, Inc.]. Cells were dissociated by mechanical trituration and seeded onto poly-l-lysine (MW 70,000; Sigma, St. Louis, MO) -coated glass coverslips (No. 1, 25-mm diameter; Fisher Scientific, Pittsburgh, PA) at a density of 150,000. Plates were maintained in an incubator at 37 C and 5% CO 2 for 3 or 6 days in vitro (DIV; time of plating ϭ 0 DIV) until experimentation on 4 or 7 DIV.
Hormonal treatments
Treatment groups are summarized in Table 1 . Cells imaged on DIV 4 were incubated in SCM containing 10 Ϫ10 m estradiol benzoate (Sigma) in dimethylsulfoxide (DMSO; Sigma) or DMSO alone at the time of plating (DIV 0). Final DMSO concentration was 0.01%. Treated SCM was replaced with fresh treated SCM each subsequent day for 3 DIV. Cells that were imaged on DIV 7 were treated in the same manner, except that cells were incubated with untreated SCM from DIV 0 -DIV 2 and then treated for 4 DIV beginning on DIV 3. Treated SCM was always removed and replaced with untreated SCM before imaging. Hormone treatment from DIV 0 -DIV 3 and DIV 3-DIV 6 encompassed times when in vivo levels of aromatizable testosterone (25) and hypothalamic levels of estradiol (26) , respectively, are elevated in male rat fetuses.
[Ca 2ϩ ] i measurement and calibration
Cells were washed with 2 ml standard perfusion solution (134 mm NaCl, 5 mm KCl, 1 mm MgCl, 3 mm CaCl 2 , 10 mm HEPES, 25 mm glucose, pH 7.4) and then incubated at room temperature for 40 -60 min in 2 ml perfusion solution containing 0.5 m of the acetoxymethyl ester form of fura-2 (fura-2/AM; Molecular Probes, Inc., Eugene, OR). Measurement of fura-2 fluorescence was performed as described previously (27, 28) .
Cells were imaged individually at the soma and were selected using the following criteria: 1) clearly distinguishable as a neuron, not an astrocyte; 2) healthy oval shape and at least one identifiable process; and 3) a cell body that was relatively isolated (i.e. not in contact with another cell body). Cells from estradiol and control-treated plates were imaged alternately. All pharmacological agents were diluted to working strength on the day of experimentation, perfused over cultures in 50-sec pulses, and allowed to wash out. The responses to 10 m muscimol (Sigma), a specific GABA A receptor agonist, and to 10 m glutamate (Sigma) were assessed in all neurons. The involvement of l-type Ca 2ϩ channels in the response to muscimol was investigated by perfusing some cells with a 100-sec preliminary perfusion of the l-type Ca 2ϩ channel blocker, nimodipine (1 m; RBI/Sigma), followed by 10 m muscimol in the continued presence of 1 m nimodipine.
At the end of experimentation on each cell, 20 m ionomycin, a Ca 2ϩ ionophore (Calbiochem, San Diego, CA), was applied to the perfusion chamber to initiate massive Ca 2ϩ influx, which served as a positive control. A cell's ability to recover rapidly from the ionomycin-induced rise in [Ca 2ϩ ] i also gave evidence of viability. Computations and calibrations were performed as previously described (27, 28) . Briefly, all fura-2 fluorescence records were corrected for background fluorescence by subtracting the light intensity measured from neurons depleted of cytosolic fura-2 by permeabilization with 20 -40 m digitonin. Values of [Ca 2ϩ ] i were derived using the ratio method (29)
, where R is the ratio F 340 /F 380 (F 340 is the fluorescence emitted by fura-2 when excited at 340 nm and F 380 is the fluorescence emitted by fura-2 when excited at 380 nm), and R min and R max are the minimum and maximum values of the ratio, attained at zero and saturating Ca 2ϩ concentrations, respectively. S f2 /S b2 is the ratio of fluorescence intensities for Ca 2ϩ -free and Ca 2ϩ -bound indicator measured with 380 nm excitation.
Reagent delivery by perfusion
When measuring cellular Ca 2ϩ responses, pharmacological agents in solution were delivered to neurons via a gravity-flow perfusion system. The delivery time of the system (time for drug solution from a reservoir to reach the neuron) was determined by monitoring the delivery of carboxyfluorescein dye. The delivery time is defined to be the time elapsed between reservoir opening and the time at which the reagent concentration at the cell reaches 10% of the peak value. For the present experiments, delivery time was 8.2 Ϯ 0.7 sec (n ϭ 17).
Analysis of Ca 2ϩ transients
The amplitude of a Ca 
Immunocytochemistry (MAP-2 immunoreactivity)
To examine the possible contributions of neuronal morphology to any effects of estradiol treatment on calcium signaling, we used standard immunocytochemistry techniques to stain for the neuronal marker, MAP-2. Cover slips were prepared as above using hypothalamic cells collected from at least ten ED-15 rat embryos. Cells were seeded at a density of 150,000 per coverslip and treated each day from DIV 0 to DIV 3 with DMSO or 10 Ϫ10 m estradiol, as described above. Briefly, cells were fixed, permeabilized, and then incubated with monoclonal anti-MAP-2 mouse primary antibody (1:1000 dilution; Sigma) in 10% goat serum in PBS, overnight, at 4 C. The following day, cells were rinsed, incubated with secondary antibody (goat antimouse biotinylated IgG; Vector Laboratories, Inc., Burlingame, CA; 1:200 dilution), and (following a PBS wash) an avidin-horseradish peroxidase complex (Vectastain ABC, Elite kit; Vector Laboratories, Inc.; 1:500 dilution) was applied for 1 h at room temperature. Cells were visualized with 0.05% 3,3Ј-diaminobenzidine tetrahydrochloride (DAB; Polysciences, Warrington, PA) and 0.001% H 2 O 2 for 10 min, rinsed again, mounted, and coverslipped.
Analysis of cellular morphology was performed under a Nikon 100 X oil-immersion objective using the Neurolucida system (MicroBrightField Inc., Colchester, VT). Five to nine cells from two cover slips of each treatment (estradiol, DMSO) were examined. The same criteria used for cell selection for calcium imaging were used to select cells for morphological analysis. The experimenter was blind to the treatment group during the analysis. The following morphological features were measured: 1) somal area (m 2 ), calculated using the formula for a polygon; 2) somal perimeter (m); 3) somal roundness (value from 0 -1, as defined in Neurolucida software program manual, v.3.22); 4) total dendritic length (m) (includes all processes of a cell); 5) primary dendritic length (m) (length of primary dendrites only); and 6) number of primary dendrites per soma.
Statistical analyses
Student's t test was used to assess differences between estradiol-and control-treated cells for each dependent variable. ANOVA was used to assess differences in levels of dependent variables among estradiol-and control-treated cells imaged on DIV 4 vs. DIV 7. Where appropriate, repeated-measures ANOVA was used to investigate differences in dependent measurements within the same cell. Percentage data were analyzed using a -square test. All statistical tests used ␣ Ͻ 0.05 as the criterion for significance.
Results
Neuronal morphology
A detailed analysis revealed that estradiol treatment did not significantly affect somal area, perimeter, or roundness, eliminating the possibility that effects of estradiol on calcium influx are a result of changes in somal morphology. Additionally, total dendritic length and number of dendrites per soma were unaffected by steroid treatment. However, there was a trend (P ϭ 0.1) for primary dendritic length to be increased by estradiol treatment, confirming the efficacy of the steroid treatment.
Effect of estradiol exposure from DIV 0 -DIV 3 on GABA-induced Ca 2ϩ flux on DIV 4
The percentage of cells responding to muscimol on DIV 4 was 85% (see Fig. 1 ) and is similar to percentages reported previously using embryonic hypothalamic cultures (6) . 0.6 sec; P Ͻ 0.05; Fig. 3B ). Once [Ca 2ϩ ] i was elevated in response to muscimol, there was a tendency for recovery to basal [Ca 2ϩ ] i to take approximately 1.5-fold longer in estradiol-treated neurons (P ϭ 0.15; data not shown).
Effect of estradiol exposure from DIV 3-DIV 6 on GABA and glutamate induced Ca 2ϩ flux on DIV 7
As expected, there was a significant decline in the percentage of cells in control cultures responding to muscimol with a Ca 2ϩ transient on DIV 7, relative to DIV 4, dropping to 35% (8/23 neurons). Importantly, estradiol treatment prevented this reduction, with 72% (18/25 neurons) of neurons from estradiol-treated cultures responding to muscimol with a calcium transient on DIV 7 (Fig. 1) . Furthermore, estradioltreated cells displayed significantly larger Ca 2ϩ transients (54 Ϯ 12 nm; n ϭ 8) after muscimol, relative to those in control cells, which averaged 21 Ϯ 5 nm (n ϭ 7; P Ͻ 0.05; Fig. 3C ). This was an increase of 61%, which is very similar in magnitude to the estradiol-enhancement of the muscimol response observed in cells imaged on DIV 4. Nonetheless, we observed the normal developmental decrease in the magnitude of the Ca 2ϩ transient amplitudes, which was about 50% lower than those in cells imaged on DIV 4 (P Ͻ 0.01), regardless of treatment. There was no significant difference in the latency to respond to muscimol in control-and estradioltreated neurons (Fig. 3D) .
Involvement of L-type Ca 2ϩ channels in the muscimol response
To determine whether l-type Ca 2ϩ channels were involved in the response to muscimol with or without estradiol, some cells imaged on DIV 4 were perfused with the l-type Ca 2ϩ channel blocker, nimodipine. A mean Ca 2ϩ transient amplitude of 71 Ϯ 12 nm after muscimol in control cells, was reduced to 13 Ϯ 5 nm in the presence of 1 m nimodipine, a reduction of 82% (n ϭ 4; P Ͻ 0.001; Fig. 4) . Similarly, a mean Ca 2ϩ transient amplitude of 104 Ϯ 16 nm in estradiol-treated cells was reduced to13 Ϯ 5 nm in the presence of 1 m nimodipine, a reduction of 89% (n ϭ 4; P Ͻ 0.001; Fig. 4) . The magnitude of the reduction is consistent with a previous study in which nimodipine greatly attenuated GABAinduced Ca 2ϩ transients in embryonic hypothalamic cultures (6) . Our present results demonstrate no difference between estradiol and control cells in the extent to which nimodipine attenuated GABA-evoked Ca 2ϩ transients, suggesting that estradiol does not exert its effects by recruiting new routes of Ca 2ϩ entry.
Glutamate-induced Ca2ϩ flux
The effects of estradiol were specific to muscimol-induced Ca 2ϩ responding cells. Thus, estradiol treatment did not increase the number of cells responding to glutamate with excitation. The percentage of cells responding to glutamate on DIV 4 and DIV 7 was 80% and 67%, respectively. Similarly, estradiol treatment did not significantly affect gluta- 
Discussion
GABA, acting at the GABA A receptor, has an excitatory depolarizing effect on immature neurons that gradually becomes inhibitory as development progresses (6) . We report here that estradiol both increases the amplitude of Ca 2ϩ transients induced by muscimol and extends the developmental time course of excitatory responses to GABA. This is the first report of steroidal modulation of cytosolic Ca 2ϩ transients evoked by an excitatory amino acid, and it suggests a mechanism of action for estradiol's trophic actions in the nervous system, particularly during sexual differentiation.
We have proposed previously that excitatory GABA is a major mediator of brain sexual differentiation (20) , based on our observations of sex differences in both GAD mRNA and GABA levels in the developing hypothalamus (21, 22) . We have now established a causal relationship between increased GABA levels and masculinization (23, 24) . Sex differences in synaptic patterning, mediated by neonatal estradiol, are found throughout the hypothalamus, including the medial preoptic, ventromedial, and arcuate nuclei (2) . Sexual differentiation of the brain is mediated primarily by estrogens aromatized from testicularly-derived androgens, released in two separate surges on ED 18 and day of birth. The observation that cultured hypothalamic neurons exhibit enhanced responses to excitatory GABA after exposure to estradiol implicate this as a potential mechanism in the differentiation process. By increasing cytosolic [Ca 2ϩ ] i and the length of time that [Ca 2ϩ ] i is elevated, excitatory GABA could mediate various estradiol-induced actions in the developing brain, including neurite extension, dendritic branching (30) , and neuronal migration (31) . Our present results also have implications for understanding estrogen's actions in the adult brain, in which GABA becomes excitatory after injury (12). Whether this phenotypic shift is protective or damaging is unknown. The possibility exists for estradiol enhancing adult excitatory GABA and may be a potential contributor to the well-known neuroprotective effects of estrogens (32) (33) (34) .
The maintenance of excitatory GABA in the presence of estradiol, compared with its developmental loss in the absence of steroid, results in two highly dimorphic phenotypes. Excitatory GABA rapidly converts to inhibitory GABA after even slight shifts in the transmembrane chloride gradient caused by shunting inhibition (35) . Inhibitory GABA results in low continuous intracellular Ca 2ϩ (36) , as opposed to the acute Ca 2ϩ transients induced by excitatory GABA. These opposing calcium profiles can produce unique patterns of phosphorylation and dephosphorylation of proteins within the cell, as observed in response to electrophysiological paradigms producing LTP vs. LTD (37) . Thus, excitatory vs. inhibitory GABA may serve as a major divergence point in estradiol-mediated sexual differentiation of the brain.
The mechanism by which estradiol enhances excitatory GABA is unknown but can be inferred from the present data. We have investigated previously the potential for hormonal influence of GABA A receptors in the developing brain, and we found no effect on receptor binding (38) or expression levels of two developmentally regulated receptor subunits (39) , making it unlikely that estradiol modulates responses to muscimol in neonatal hypothalamus by altering GABA A receptors. It is equally unlikely that estradiol alters l-type calcium channels directly, for example, by increasing the number of channels. Various signaling molecules alter membrane excitability by activating voltage-gated Ca 2ϩ channels; and thus, this is a promiscuous response that is not selective to GABA action. Opening l-type calcium channels requires sufficient depolarization (40) , which, for excitatory GABA, is dependent on the chloride reversal potential. This gradient is the primary determinant of excitatory vs. inhibitory GABA action and is the result of differential expression of at least two chloride cotransporters. In adult brain, where GABA is hyperpolarizing (i.e. inhibitory), an electroneutral K ϩ -Cl Ϫ cotransporter, KCC-2, is widely expressed and maintains a mature chloride gradient (13) . In contrast, BSC-2 transports Cl Ϫ into immature neurons in which GABA is depolarizing (i.e. excitatory) and is heavily expressed in brain during the first postnatal week, declining thereafter (41) . Several features of our results are consistent with estradiol modulating expression of these cotransporters to retain an immature chloride gradient profile. In particular, estradiol maintained an excitatory response to muscimol as development proceeded, suggesting that these neurons had a chloride reversal potential characteristic of neonates, allowing a depolarizing response to GABA A receptor activation. Furthermore, we found that the enhancing effect of estradiol on excitatory GABA was mediated by l-type Ca 2ϩ channels and did not involve recruitment of an additional mechanism. This further implicates changes in the transmembrane Cl Ϫ gradient as a potential mechanism by which estradiol enhances excitatory GABA.
By increasing intracellular calcium after depolarization (10, 42) , GABA exerts well-documented trophic actions in the nervous system (9, 10, 14, 43) . Calcium influx is uniquely suited to couple changes in cellular excitability and gene expression because Ca 2ϩ signals generated by electrical activity can activate signal transduction pathways, inducing various transcription factors (44, 45) . The immediate early gene, c-fos, is rapidly transcribed in response to increases in intracellular Ca 2ϩ (46, 47) , and c-fos may stimulate the synthesis of neurotrophins like nerve growth factor and brainderived neurotrophic factor and their receptors, which may be involved in sexual differentiation of the brain.
